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Abstract 
This is a descriptive, cross sectional, hospital based study 
conducted between August 2004 -February 2005. 
Five hospitals representing Khartoum State were selected, 
including Omdurman Maternity Hospital (OMH), Soba University 
Hospital (SUH), Khartoum Children Emergency Hospital (KCEH), 
Omdurman Children Emergency Hospital (OCEH) and Ahmed Gasim 
Hospital (AGH). 
 The purpose was to study the clinical Pattern of neonatal 
seizures, possible underlying causes and to determine short term 
outcome in the acute illness and neonatal period.  
Seventy five newborns with neonatal seizures from the first 
attack and throughout the neonatal period were studied. The 
admissions represented 2.3%, 1.5% of INCUs admissions in OMH 
and SUH respectively and 0.21%, 0.23% and 0.07% of general 
pediatric case admissions in KCEH, AGH and OCEH respectively. Of 
the seventy five newborns, 61.33% developed seizures within the first 
48 hours of age. 
 III 
The study found that the neonatal sepsis and birth asphyxia 
were the principal etiological factors in 53%, 25% of cases, 
respectively.              
The findings of the clinical pattern of the seizures were 55 
(73.33%) multifocal, 10 (13.33%) focal, seven (9.33%) tonic, two 
(2.7%) subtle and one (1.3%) myoclonic seizures. 
Poor prognosis was associated with neonatal sepsis, birth 
asphyxia, multifocal, focal seizures and development of seizure in the 
first 48 hours of age. The mortality was 18 (24%) cases mainly during 
the acute illness and only one during the neonatal period. 
Detectable causes of neonatal seizures in our environment 
appear to be potentially preventable by improved obstetric and 
neonatal care. There is bad need also to provide modern facilities for 
investigating newborn seizures in order to improve upon diagnostic 
yield and better management. 
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               1- Introduction and Literature Review 
1.1- Historical Background: 
      Throughout early medical writings only three types of neurological 
disorders were recognized. References to various sorts of seizure 
disorder, and to palsies and hydrocephalus appear in the literature 
from Hippocrates onwards. 
      Hippocrates observed that convulsions both accompanied and 
were sequels to feverish illnesses. Rigors (shivering fits of irregular 
times) were clearly differentiated from seizures both in 
generalizations on the complications of febrile states and in specific 
case histories. Generalized seizures, in which loss of voice , choking , 
foaming at mouth , clenching of the teeth and convulsive movement 
of hands, fixed eyes, unconsciousness and  variable faecal 
incontinence were observed, and partial attacks in which the mouth 
may be distorted, or an eye, a hand or the neck ; were all recognized 
. 
     Hippocrates was also cognizant of breath-holding attacks, when 
sobs will not let him take in a birth quickly enough, as often happens  
with children. (1)  
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1.2- Definitions: 
1.2.1- Gestation (independent of birth weight);                 
   Gestational age: The duration of gestation measured from the first 
day of the last menstrual period and expressed in complete weeks or 
days. (2) 
1.2.1.1- Preterm = less than 37 completed weeks of gestation (< 259 
days). (2) 
1.2.1.2- Full-term = between 38 weeks and 42 completed weeks of 
gestation (259-293 days). (2) 
1.2.1.3- Post-term or post mature = more than 42 completed weeks 
(294 days). (2) 
1.2.2- Birth Weight (independent of gestation);  
The first weight of fetus or newborn infant obtained after birth 
(preferably within the first hour.)  (2)  
1.2.2.1- Low Birth Weight (LBW) = Less than 2500 g. (3)  
1.2.2.2- Very Low Birth Weight (VLBW) = Less than 1500 g. 
(accepted by convention). (3)   
1.2.2. 3- Extremely Low Birth Weight (USA- very, very low birth 
weight) = Less than 1000g (accepted by convention). (3) 
 
 3 
1.2.2.4-Impossible or Incredibly Low Birth Weight = Less  
than750g.(3)  
1.2.3- Size for Gestation;  
1.2.3.1- Small for Gestation = Less than 10th centile in weight 
expected for gestation (small for date). (3)  
1.2.3- Size for Gestation;  
1.2.3.1- Small for Gestation = Between 10th and 90th centiles of 
weight expected for gestation. (3)  
1.2.3.3- Large for Gestation = More than 90th centile in weight 
expected for gestation. (3) 
1.2.4- AGE 
1.2.4.1- Perinatal Period = The period from 28 weeks gestation or 
the time of the live birth if less than 28 weeks gestation to 7 days of 
postnatal age. (3) 
1.2.4.2- Early Neonatal Period= The first 7 days of life of alive born 
infant of any gestation. (3)  
1.2.4.3- Late Neonatal Period = 8-28 days after birth. (3)  
1.2.4.4- Neonatal Period = The first 28 days of life of alive born 
infant of any gestation. (3) 
1.2.4.5- Infant = The first year of life. (3) 
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1.2.5- MORTALITY RATES    
1.2.5.1- Still Birth Rate = Number of stillbirths per 1000 total births.(3) 
1.2.5.2- Perinatal Mortality Rate (PMR) = Number of stillbirths + 
early (up to 7 days) neonatal deaths per 1000 total births. (3) 
1.2.5.3- Neonatal Mortality Rate (NMR) = Number of deaths in the 
first 28 days per 1000 live births.   The corrected WHO neonatal 
mortality rate is the number of deaths in the first 28 days of life (birth 
weight greater than 1000 g ) per 1000 live births. (3)  
1.2.5.4- Infant Mortality Rate (IMR) = Number of deaths in the first   
365 days per 1000 live births. (3) 
1.2.6- Neonatal Period: 
     Although the neonatal period is considered to be the first 4 weeks 
of life, both fetal and extra uterine life form a continuum during which 
human growth and development are affected by genetic, 
socioeconomic and environmental factors. For example, maternal 
toxemia may decrease the rate of fetal growth and cause an increase 
incidence of neonatal hypoglycemia. Low economic status is 
frequently associated with prematurity, which is correlated with high 
rates of morbidity and mortality, not only in the neonatal period but 
also throughout infancy. Cultural factors, failure of use prenatal and 
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preventive medical care also contributes to fetal and infant morbidity 
and mortality.  An infant intrauterine to extra uterine transition 
requires many biochemical and physiologic changes and no longer 
dependent on maternal circulation via placenta. Many of newborn’s 
special problems are related to poor adaptation due to asphyxia, 
premature birth, life – threatening congenital anomalies, or adverse 
effects of delivery. The neonatal period is a highly vulnerable time for 
an infant, who is completing many of the physiologic adjustments 
required for extra uterine existence and the high neonatal morbidity 
and mortality rates attest to the fragility of life during this period. (4, 5)     
1.2.7- A seizure (convulsion):                                                                         
Is a paroxysmal involuntary disturbance of brain function that may   
be manifested as impairment or loss of consciousness, abnormal 
motor activity, behavioral abnormality, sensory disturbance or 
autonomic dysfunction. Some seizures are characterized by 
abnormal movement without loss or impairment of consciousness. 
Seizures do not constitute a diagnosis, but are symptom of an 
underlying central nervous system (CNS) disorder that requires        
a through investigations and management plan. Epilepsy is recurrent 
seizures unrelated to fever or an acute cerebral insult. (6, 7) 
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     Neonatal seizures are a very common symptom. They may be the 
first manifestations of neurological and non-neurological (e.g. 
endocrinological) dysfunction and they have been statistically 
correlated with morbidity and mortality in form of following epilepsy, 
cerebral palsy, and developmental delay. (8, 9) The outcome of infants 
with neonatal seizures is also not well established. Seizures in a 
newborn infant are often important because they can indicate a 
disturbance of central nervous system. It is critical to recognize 
neonatal seizures, to determine their etiology, and to treat them for 
three major reasons. First, the seizures are usually related to 
significant illness, sometimes requiring specific therapy. Second, 
neonatal seizures may interfere with important supportive measures, 
such as alimentation and assisted respiration for other associated 
disorders frequently present in neonates. Third, experimental data 
give reason for concern that the seizures per se may be a cause of 
brain injury and mental retardation and / or cognitive delay. (10) 
The immature central nervous system is particularly susceptible to 
seizures, which are more common in newborn babies than at any 
other time of life. The vulnerability of the neonatal brain to seizures is 
thought to be due to combination of enhanced excitability with an 
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abundance of neuromuscular depolarizing agents (NMDA) binding 
sites and low levels of the inhibitory neurotransmitter gamma 
aminobuteryic acid (GABA).(11) This may reflect the earlier 
development of excitatory synapses, predominating over inhibitory 
influences at early stages of maturation. (12) 
Neonatal seizures are dissimilar from those in child or adult because  
generalized tonic colonic convulsions tend not to occur during the first  
month of life. The arborization of axons and denderitic processes as 
well as myelination is incomplete in neonatal brain. A seizure 
discharge therefore cannot readily be propagated throughout the 
neonatal brain to produce a generalized seizure. (4, 5) Neonatal 
seizures differ in clinical descriptions from those in adults, and 
seizures in preterm infants differ from those in term infants. Cerebral 
cortical organization, synaptogenesis, and myelination of cortical 
efferent pathways are poorly developed in human neonates, leading 
to weakly propagated, fragmentary seizures whose electrical activity 
may not spread to surface EEG electrodes. The more advanced 
development within the limbic system with connections to mid-brain 
and brain stem may explain the higher frequency of mouthing, eye 
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deviation, and apnea in neonates than seizures in adults. Thus, the 
clinical manifestations can be extremely inconspicuous in neonates.(8)   
 1.3- Incidence: 
   Seizures occur in 0.7-2.7 per 1000 of infant born at term, (12, 13) 
57.5-132 per 1000 of preterm infant of very low birth weight and the 
incidence of electrographic (clinically silent) seizures is unknown. (12) 
Seizures occur in 6-13 % of very low birth weight, and 1-2 per 1000 of 
infants born at term. Other series did not usually discriminate 
between term and preterm infants, and reported higher incidence 
figures. (11) Asindi et al (14) reported incidence of 3%, Ariede et al (15) 
of; 7.5/1000 live birth (8/1000 term and 47.6/1000 preterm) and 
Omene et al (16) of 3.5/1000 neonate (3.7/1000 term and 13.5/1000 
preterm) in Nigerian neonate. The incidence of electrographic 
(clinically silent) seizures is unknown. Continuous EEG monitoring of 
infants after one clinical seizures showed that 79% of subsequent 
EEG seizures were silent, (12,17) Such phenomena seem to be more in  
preterm infants.(12,18) 
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1.4- Clinical Types of Neonatal Seizures 
    Classically, there are four recognizable clinical seizures types: 
subtle, colonic, tonic and myoclonic. Based on the descriptions of  the 
quality and distributions of seizure behaviors. Each can be focal, 
multifocal (involves more than one site, is asynchronous, and often  
migratory), and generalized (diffusely bilateral, synchronous, and 
non-migratory). (8, 12, 19)Focal seizures consist of rhythmic twitching of 
muscle groups, particularly those of the extremities and face. 
Multifocal colonic convulsions are similar to focal colonic seizures but 
differ in that many muscle groups are involved, frequently several 
simultaneously. (6, 7, 12, 19)    Neonatal seizures are clinically significant 
because very few are idiopathic. Further investigation leading to   
prompt diagnosis of underlying condition is important because many 
of the aetiologies have specific treatments which, when used early, 
may improve the prognosis. (12)  
1.4.1- Subtle Seizure:  
This type of seizures is more common in preterm than in term infants.  
Manifestations of subtle seizures include oro-facial symptoms such 
as eyelid deviation, eyelid blinking, sucking, chewing and lip 
smacking. Limb movements described as swimming, boxing or 
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cycling can also indicate subtle seizure activity. (8, 11, 12, 19)  EEG 
changes most likely with ocular manifestations. (12, 19) Apnoea can be 
manifestation of subtle seizure although most apnoeic episodes in 
preterm infants do not represent seizure activity. Such non-convulsive 
apnoea is usually associated with  bradycardia. (12, 19, 20) Convulsive 
apnoea, associated with EEG seizure activity, is more likely in term 
infants, particularly if the apnoea is not accompanied by bradycardia 
but is associated with other subtle phenomena, such as eye opening, 
fixed staring and deviation of eyes. (12, 19, 21) It can be difficult to 
distinguish subtle seizures from jittering. Jitteriness is a common 
benign neonatal movement disorder characterized by symmetrical  
rhythmic tremor of equal rate and amplitude involving the extremities 
and sparing the face.(8,12,19)  Occurring at a higher frequency than 
colonic movement (5-6 per second). Jitteriness is generally induced 
by an external stimulus and ceases with gentle restraint or passive 
flexion.(11,12,19)  The autonomic nervous system changes of a seizure,  
such as tachycardia or hypertension, are never seen in jittering. (11)  
It occurs in infants without neurological impairment and is not 
necessarily an abnormal feature. The most commonly identified 
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causes are hypoxic-ischaemic encephalopathy, hypoglycaemia, 
hypocalcaemia and drug withdrawal. (12,19)       
1.4.2- Colonic Seizure:         
Colonic seizures usually involve one limb or one side of the face or 
body jerking rhythmically at a slow frequency of 1-4 times per second. 
Colonic seizures are often a clue to an underlying focal lesion such 
as a cortical infarction, but can be due a metabolic cause. It is 
important to differentiate colonic seizures in the newborn as focal or 
multifocal. Focal colonic seizures involve, face, upper and/or lower 
extremities on one side of the body, or axial structures on one side of 
the body. On the contrary, multifocal colonic seizures involve several 
body parts, often in a non-Jacksonian fashion. (8, 11, 12, 19) This type of 
seizures is associated with a characteristic EEG discharge consisting 
of runs of focal sharp wave complexes which spread ipsilaterally from 
the hemisphere in which they originate. Infants are not usually 
unconscious during colonic seizures. (11)  
1.4.3- Tonic Seizure: 
      Sustained posturing of the limbs or trunk, or deviation of the head 
or eyes are the usual manifestation of tonic seizures in newborn. This 
type of seizure is usually associated with a characteristic EEG 
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signature of high frequency sharp waves. (8,11,12.19) There are two 
categories of tonic seizures : focal and generalized. Focal tonic 
seizures consist of sustained posturing of a limb or asymmetric 
posturing of trunk and/or neck. Generalized tonic seizures are 
characterized most commonly by tonic extension of both upper  
and lower extremities but also by tonic flexion of upper extremities 
with extension of lower extremities,(8) accompanied by pronation of 
arms and clenching fits. (12, 19)  
1.4.4- Myoclonic Seizure: 
    Myoclonic jerks tend to occur in the flexor muscle groups. In rare 
cases, generalized myocolonic seizures resemble salaam spasms 
and are most likely associated with EEG change. (8, 11) Three 
categories of myoclonic seizures should be distinguished: focal, 
multifocal and generalized. Focal myoclonic seizures typically involve 
flexor muscles of an upper extremity. Multifocal myoclonic seizures  
are characterized by asynchronous twitching of several parts of the 
body. Generalized myoclonic seizures are characterized by bilateral 
jerks of flexion of upper and sometimes also lower limbs. (8, 22)  
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1.4.5- Common Epileptic Syndromes 
      Four epilepsy syndromes occurring in the neonatal period have 
been delineated. (8, 23) 
1.4.5.1- Benign Idiopathic Neonatal Convulsion (Fifth day fits):    
   These seizures occur between day1and 7 of life, mostly between 
day 4 and 6. The prevalence is 4% of neonatal seizures. These 
seizures are usually partial colonic with alternating sides. A typical 
interictal EEG pattern that appears in 60% of neonates with this  
condition is a discontinued theta rhythm. Outcome is good with no 
recurrence of seizures or cognitive deterioration, (8, 23) generally 
seizures cease within 15 days. The cause is unknown although low 
cerebrospinal fluid zinc concentrations have been described in some 
cases. (11, 12, 24) Very few cases have been reported recently. The term 
“fifth day fits” probably represents a meaningless diagnosis and  
should be avoided. (12) 
  1.4.5.2- Benign Familial Neonatal Convulsion: 
    These seizures are dominantly inherited. In most patients, they 
start on the second or third day of life, but also can begin during the 
third month. The seizures are usually colonic, and there are no 
specific EEG criteria. Outcome is favorable, with only 14% of these 
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children continuing to have seizures at later stage. Most kindreds 
showed linkage to chromosome 20q. While linkage to this 
chromosome could not be demonstrated in some families, one  
kindred did show linkage to chromosome 8q, thus demonstrating the 
genetic heterogeneity of the syndrome. Mutations in the voltage 
gated K+ channel gene KCNQ2 are known to cause benign familial 
neonatal convulsions. Most KCNQ2 mutation can be predicted to 
truncate the protein. Only few amino acid exchanges have been 
found, and their localization was restricted to either the pore region of 
fourth or sixth transmembrane regions.  
    Dedek et al (8, 23, 25), identified the first KCNQ2 mutation located 
within transmembrane region 5. The clinical history of two affected 
family members is not compatible with typical benign familial neonatal 
convulsion. The poor outcome in the index patient raises the question 
if at least some KCNQ2 mutations might increase the risk to develop 
therapy resistant epilepsy. Additional studies are needed to evaluate 
the possibility of a causal relationship between KCNQ2 mutations and 
early infantile epilepsy. (8, 23, 25)  
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1.4.5.3- Early Infantile Epileptic Encephalopathy with 
Suppression Bursts: Ohtahara Syndrome  
    This syndrome has an onset within the first 3 months of life,  
mainly during the first month. It is characterized by frequent tonic 
spasms, sometimes in clusters. There are also less frequent partial  
seizures and rare myoclonic seizures; EEG evidence shows  
suppression-brust patterns both in awake and sleep states. The 
etiologies are heterogeneous, but this syndrome is usually associated 
with structural brain anomaly. The prognosis is very poor, with either 
early death or marked psychomotor retardation and intractable  
seizures.(8,12, 19, 23, 26, 27) It can evolve into West syndrome.(28) 
1.4.5.4- Early Myoclonic Epileptic Encephalopathy:  
   The seizures nearly always start in the neonatal period but can 
appear as late as 3 months of age. The seizure types include 
fragmentary myoclonus, massive myoclonus, partial seizures, and 
tonic spasm. Prognosis is very poor, with either early death and/or 
severe psychomotor retardation. (8, 23, 29)  
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1.5- EEG Classification of Neonatal Seizures  
1.5.1 Clinical Seizure with a Consistent EEG Event: 
    A clinical seizure occurs in relationship to seizure activity on the 
EEG and includes focal colonic, focal tonic, and some myoclonic 
seizures. These seizures are clearly epileptic and are likely to 
respond to an anticonvulsant. 
1.5.2- Clinical Seizures with Inconsistent EEG Events:  
   A clinical seizure without a corresponding seizure discharge, is  
observed with all generalized tonic seizures and subtle seizures and 
with some myoclonic seizures. These infants tend to be 
neurologically depressed or comatose as a result of hypoxic ischemic 
encephalopathy. Seizures in this category are likely to be of non 
epileptic origin and may not require or respond to antiepileptics. 
1.5.3- Electrical Seizures with Absent Clinical Seizures: 
Electrical seizures associated with a markedly abnormal background  
EEG may develop in comatose infants who are not on 
anticonvulsants. Conversely, electrical seizures may persist in  
patients with focal tonic or clonic seizures without clinical signs  
after the introduction of anticonvulsant. (6, 7)   
        For the electroclinical dissociation two explanations have been  
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proposed. The first is that some seizures may originate at   
a subcortical level (myoclonic) and are not propagated to surface  
electrodes because the immature synaptogenesis and cortical  
projections. (8, 12) The second is that subtle and generalized tonic  
seizures are not, in fact, epileptic due to central nervous system  
hypersynchronous electrical discharge, but are primitive brain stem  
and spinal motor patterns released from tonic inhibition normally  
exerted by the forebrain. (8, 12, 30) In a recent study, it has been  
demonstrated that the type of ictal discharge is related to gestational 
age: there is a rich Variety in the onset, morphology, and frequency of 
the ictal discharge in both preterm and full term infants and neonatal 
ictal patterns lack a close correlation with underlying pathology. (8)  
Continuous EEG recording is recommended for infants who are  
paralyzed, to detect the frequency and duration of seizures. 
Unfortunately access to routine EEG monitoring is very limited in  
most clinical settings and interpretation is very observer dependant, 
requiring considerable experience. This greatly reduces the value of 
this technique. A more convenient form of continuously monitoring 
seizure and background activity is to use the modified amplitude 
integrated EEG or cerebral function monitor (CFM). (12) Seizures can 
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be recognized by a period of higher voltage activity with a narrow 
range of voltages, compared with background activity. CFM output 
needs to be interpreted with caution as artifacts, such as movement, 
will be erroneously recorded as cerebral activity, transient 
disturbances may be overlooked because of the compressed time 
scale, and low frequency seizures may be filtered. Any form of 
continuous monitoring will also detect clinically silent seizures in   non  
paralyzed infants, particularly preterm infants, which are of uncertain 
clinical importance. (12, 31) However, it has been shown that 
approximately half of all neonatal seizures may be missed using CFM 
alone. Neonatal seizures need to be diagnosed, characterized, and 
quantified first using EEG; the CFM may be useful for long term 
monitoring. (8, 32)  
1.6- Pathophysiological Mechanisms of Neonatal     
Seizures             
       Clinically, a seizure appears when there is an excessive 
synchronous electrical discharge, for example depolarization of 
neurons within the cortex of central nervous system. The fundamental 
mechanisms of neonatal seizures are generally unknown, but current 
data suggest that the excessive depolarization may result for at least 
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these following reasons: disturbance in energy production can result 
in a failure of the sodium-potassium pump. Hypoxemia, ischemia, and 
hypoglycemia can cause an abrupt reduction in energy production. 
Excess of excitatory versus inhibitory neurotransmitter can result in 
an excessive rate of depolarization. In presence of hypoxemia,  
ischemia and hypoglycemia, the extra-cellular level of glutamate      
(a principal excitatory extracellular in cortex) can increase for 
excessive release and diminished reuptake: this situation can cause 
an excessive neuronal excitation. A relative deficiency of inhibitory 
versus excitatory neurotransmitter can result in an excessive rate of 
depolarization. For example, the brain concentration of GABA          
an inhibitory neurotransmitter, is decreased when the activity of its 
synthetic enzyme, glutamic acid decarboxylase, is depressed.(8, 33) 
 
     Finally, Calcium and magnesium interact with the neuronal 
membrane to cause an inhibition of sodium movement.Consequently, 
hypocalcaemia and hypomagnesaemia would be excepted to cause 
an  increase in  sodium influx and depolarization. (8, 10)   
      Physiological Changes during Seizures: 
    Blood glucose remains normal or rises during seizure, but brain 
glucose falls markedly. This implies that brain transport mechanisms 
 20 
are unable to keep up with the increased demand. The demand for 
oxygen is also increased, and cerebral blood flow rises to try to meet 
the need for oxygen and glucose. That metabolic demand outstrips 
supply in the newborn is supported by magnetic resonance 
spectroscopic data showing a shift in spectra form the high energy 
phosphate compounds towards inorganic phosphate. (11, 34) 
       Glucose pretreatment is effective in reducing the high mortality of 
status epilepticus in rats, a benefit which is not seen with ketone body  
supplementation, although the neonatal brain is known be able to 
utilize alternative fuels. Lactate accumulates during seizure, and the 
arterial ph falls. Systemic blood pressure increases in seizures with 
marked pathological activity. (11)       
1.7- Aetiology  
   Many pathologies can give rise to neonatal seizure, although only a 
few of these conditions account for most seizures. Very few neonatal 
seizures are idiopathic (2-5%). (12)  
1.7.1- Major Causes of Neonatal Seizures 
1.7.1.1- Hypoxia-Ischaemia: 
    Hypoxic-ischaemic encephalopathy (HIE) insult (asphyxia) account 
for about 50% of cases of neonatal seizures. (8, 11, 12, 35) Most 
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asphyxiated infants with seizures have a moderate degree of 
encephalopathy(36) presenting with subtle, focal, or multifocal 
fragmentary colonic seizures, usually within the first 24 hours. 
Myoclonic and tonic seizures can occur in the most severe form of 
HIE and can be difficult to control pharmacologically. Other insults 
such as hypoglycaemia, hypocalcaemia, and subarachnoid 
haemorrhage may coexist and trigger postasphyxial seizures. 
Isolated periventricular leucomalacia (PVL), in the absence of other 
aetiologies, is a relatively rare cause of neonatal seizures. (8, 11, 12)  
1.7.1.2- Central Nervous System Infection:  
   Most forms of central nervous system infections are associated to 
seizures that may be the first presentation. The most commonly 
isolated pathogens are Group B Streptococcus, Escherichia coli, 
Listeria spp, Staphylococcus and Pseudomonas species. (8, 11, 12) Viral 
infection is involved in the genesis of neonatal seizures, such as for 
example, herpes simplex encephalitis and intrauterine 
infections.(8,11,12,37,38)  
1.7.1.3- Intracranial Haemorrhage:  
    Subdural and subarachnoid haemorrhage can occur in term infants 
following birth trauma and may cause seizures independently of any 
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associated asphyxial insult. In preterm infants severe intraventricular 
haemorrhage, with or without associated parenchymal venous 
infarction, can be followed within a few hours by generalized tonic 
seizures. (8, 11, 12) Isolated germinal matrix haemorrhages are unlikely 
to produce seizures. (8, 12)   
1.7.1.4- Cerebral Artery Infarction: 
   In infant presenting with seizures, whose Apgar score was normal 
and subsequent investigations failed to reveal an infective or 
metabolic aetiology, (8,11,12) a high percentage of ischaemic lesions 
were demonstrated by early magnetic resonance imaging before 
changes on cranial ultrasound scan become apparent. (12, 39) Focal 
infarcts may be caused by polycythaemia, protein C or S deficiency, 
maternal lupus, factor V Leiden or emboli from placenta. (11)    
1.7.1.5- Acute Metabolic Disturbance: 
  Hypoglycaemia is the cause of convulsions in only 3% of cases,(12,40) 
although it occurs frequently in infants with seizures because it 
coexists with other causes, such as hypoxia-ischaemia, infection, and 
also common in infants who are small for gestational age.(11,12) 
Hypoglycaemia can be the sole cause of neonatal seizures and other 
neurological symptoms as apnoea, lethargy and jitteriness. (11)  
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The definition of hypoglycaemia is also debated.The level constituting 
a risk of neurological impairment is variable, depending on metabolic 
state of the infant. Nevertheless, when faced with a convulsing infant 
whose blood glucose is below 2.6 m mol/l, most clinicians would 
advocate correction of the perceived hypoglycaemia.(12)  
       Hypocalcaemia presents typically either within the first 3 days of 
life or later in the neonatal period. Early onset hypocalcaemia occurs 
in infants of diabetic mothers, low birth weight infants and after 
exchange transfusion.  Hypocalcaemia can also occur in association  
with other aetiologies, particularly hypoxia-ischaemia. Thus early 
hypocalcaemia is often associated with neonatal seizures, although it 
is the sole cause in only about 3%. (12, 40) Late onset hypocalcaemic 
convulsions are now rare. The incidence of late onset hypocalcaemia 
has fallen following the introduction of low phosphate milk 
formula.(11,12) Hypocalcaemic seizures occasionally occur secondary 
to maternal hypercalcaemia (prolonged intrauterine exposure to high 
levels) or maternal vitamin D deficiency, and neonatal diagnosis 
should prompt estimation of the maternal serum calcium. 
Hypomagnesaemia frequently accompanies hypocalcaemia and may 
require correction before the seizures will respond. Hypocalcaemia is 
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common in ill VLBW babies and with HIE, and is not causally related 
to the seizures in these cases. (11)  
  Hyponatraemia, hypernatraemia or rapidly changing serum sodium  
occurring in conditions  such as the syndrome of inappropriate ADH  
secretion, Bartter syndrome or sever dehydration can cause 
seizures.(11,12)   
1.7.2- Less Common Causes 
1.7.2.1- Inborn Error of Metabolism: 
    Are a rare cause of neonatal seizures and should be considered 
when seizures are unresponsive to conventional treatment in 
neonates with a positive family history, recent introduction of milk, 
acidosis, or distinctive odour: aminoaciduria, urea cycle 
defects(ornithine transcarbamylase, arginosuccinic lysate, and 
carbamoylphosphate synthetase deficiencies), organic acidopathies, 
peroxisomal disorders. (6, 7, 12)   
Glycine encephalopathy; non-ketotic hyperglycinaemia is a rare 
inborn error of metabolism in which large amounts of glycine 
accumulate, causing intractable seizures. Hiccups can be 
troublesome. Levels of glycine in blood, urine and CSF are very high. 
In one case dextromethorphan monotherapy (35 mg/Kg/day) was 
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associated with cessation of seizures and normalization of EEG, but 
this regimen was not successful in another infant. (11)     
1.7.2.2- Pyridoxine dependency:  
   Is a rare autosomal recessive disorder causing sever neonatal 
epilepsy. Seizures usually occur during the first few days of life, but 
these may occur either in utero or subsequently in infancy (30 
minutes to 3 days of life) or early childhood. (6, 7, 41, 42, 43, 44) Although 
the underlying defect remains unknown, pyridoxine dependent 
seizures seem to be due to deficiency of brain gamma amino butyric 
acid (GABA), a major inhibitory neurotransmitter of the central 
nervous system. (6, 7, 12, 41, 45) Pyridoxal phosphate (PLP), the active 
metabolite of pyridoxine, is the coenzyme for glutamate 
decarboxylase(GAD), the rate limiting enzyme for the production of 
GABA from glutate. A glutamate excess may also be neurotoxic in 
this condition. (41)  Presents with early onset intractable seizures. The 
EEG may show generalized bursts of bilaterally synchoronous high 
voltage 1-4 Hz activity with interspersed spikes, (12,45) but the 
diagnosis is established by observing cessation of seizures within 
minutes of administering 50-100 mg pyridoxine (normalization of the  
EEG may be more gradual). (12)  
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1.7.2.3- Congenital Malformation of The brain:  
   Sever cytoarchitectural abnormalities of the brain including 
lissencephaly and schizencephaly who clinically may appear normal 
or microcephalic. (6, 7, 11)  
1.7.2.4- Neonatal Drug Withdrawal (maternal drug intoxication): 
   Is a common of neurological signs for example, jitteriness, diarrhea 
and autonomic dysfunction and only about 5% will include seizures, 
usually within the first days. Drugs misused by mothers for such signs 
are usually narcotic analgesics, barbiturates, cocaine and 
alcohol.(12,46) Methadone related neonatal withdrawal seizures can 
occur any time up to 3 weeks of life, (12) and can persist for several 
months. EEG abnormalities are percent in 50% of cocaine exposed 
neonates, persist for up to one year, and associated with adverse 
neurodevelopmental outcome. (11)  Cocaine misuse may predispose 
to prenatal cerebral artery infarction which may cause seizures.(12)   
Tremors have been noted in children who received prolonged 
infusions of narcotics for analgesia. (11)  
1.7.2.5- Benign Neonatal Seizures:    
    Benign familial neonatal convulsions (BFNC) 
    Benign idiopathic neonatal convulsions (BINC. “fifth day fits”) 
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    Benign neonatal sleep myoclonus; consist of bilateral, synchrous  
myoclonic jerks occurring during quiet sleep. Onset is within the first 
week and resolves within two months. The EEG shows no abnormal 
activity between or during episodes. Neurological outcome is 
normal.(11, 12) 
1.7.2.6- Neonatal Epileptic Syndromes: 
   Early myoclonic encephalopathy (EME). 
   Early infantile epileptic encephalopathy (EIEE). (12)                          
EME & EIEE are rare, characteristically present in the first weeks with  
severe recurrent seizures and are associated with inborn errors of 
metabolism (EME) and CNS abnormalities (EIEE). (12, 47) Both lead to 
severe subsequent neurodevelopmental impairment. During the 
neonatal period the seizures are fragmentary myoclonic and colonic 
in EME, and tonic in EIEE, both showing a brust supration EEG. (12) 
1.7.2.7- Unintentional injection of a local anesthetic into fetus 
during labor can produce intense tonic seizures:    
    These infants are often thought to have had a traumatic delivery 
because they are flaccid at birth, they have abnormal brainstem 
reflexes, and they show signs of respiratory depression that 
sometimes requires ventilation. Examination may show a needle  
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puncture of the skin or a perforation or laceration of the scalp. An 
elevated serum anesthetics level conferms the diagnosis. The 
treatment consists of supportive measures and promotion of urine 
output by administering intravenous fluids with appropriate monitoring 
to prevent of fluid overload. (6, 7)          
1.7.2.8- Intra Partum Fever and unexplained seizures in term 
infants:              
    A case control study (four controls were selected for each case) 
intrapartum fever, even when unlikely to be caused by infection, is 
associated with increase in risk of unexplained ,early onset neonatal 
seizures in term infants. Infants whose mothers were febrile 
(temperature >100.40 F) during labor had a four times the risk of 
seizures of infants whose mothers were afbrile. The study indicates 
that intrapartum fever is a strong independent risk factor for 
unexplained seizures in term infants in the absence of documental 
neonatal infection. The physiologic mechanism for this association is 
uncertain but could reflect either an affect of cytokines or an increase 
in metabolic rate that exacerbates the effect of hypoxia. (48)   
1.7.2.9- Hypertension: Rapid lowering of the blood pressure with 
captopril was accompanied by a seizure in one case and 
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hypertensive seizures were reported in two cases. With increasing 
incidence of hypertension due to steroid treatment in chronic lung 
disease this may become more of a problem in coming years. (11)  
1.7.2.10- kernicterus. (11) 
1.7.2.11- Idiopathic. (12)         
1.8- Diagnosis  
   Careful history, neurological examination and investigations are 
needed to fine out the cause of the neonatal seizures.  
1.9- Investigations  
   The large differential diagnosis following neonatal seizures 
demands that any investigations should be undertaken in logical 
sequence. Certain clues to the aetiology may be present, such as 
history of perinatal asphyxia or maternal narcotic abuse, but other 
causes such as hypoglyaemia, hypocalaemia, and CNS infection may 
coexist and need excluding. The initial investigations should 
concentrate on the common aetiologes that require prompt specific 
treatment in the following suggested sequence to reveal the 
cause.(11,12) 
1.9.1- First Line;  
Pulse oximetry  
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Blood glucose 
Packed cell volume  
Serum calcium (ionized if possible) 
Serum magnesium 
Arterial pH 
Serum sodium 
Serum urea and creatinine 
Lumber puncture  
blood cultures 
Cranial ultrasound scan 
EEG 
1.9.2- Second Line;  
MRI or CT 
Maternal and neonatal samples(urine/hair/meconium) for drugs of 
abuse 
Specimens for virology and congenital infections 
Serum ammonia, amino acids 
Urinary amino acids and organic acids 
Chromosomal analysis 
Consider therapeutic trial or pyridoxine  
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1.9.3- Imaging:  
    Cranial ultrasound scanning is useful as a first line imaging 
investigation for exclusion for gross CNS pathology, CNS 
malformation and periventricular haemorrhage. But it may fail to 
detect cerebral arterial infarction, subdural and subarachnoid 
haemorrhage. If the initial ultrasound examination is normal but the 
infant continues to have seizures or has abnormal interictal  
neurological sign, CT or MRI examination should be carried out. (12)     
The value of an EEG examination has already been discussed and 
an EEG Should be obtained if at all possible, and certainly in difficult 
cases, (11) to confirm the clinical seizures, before and after having 
established the anticonvulsant treatment. (8) 
       1.10- Treatment 
    Two principles exist. The first is to detect and treat the underlying 
cause of the seizure, paying particular attention to associated acute 
metabolic disturbances, such as hypoglycaemia. The second 
principle is the assessment of need to control the seizures, which 
involves balancing the benefits of stopping some or all of the seizures 
against any potential deleterious effects of anticonvulsant medication. 
It is the second principle that provokes the greatest debate. (12) Most 
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neonatologists would treat if there were more than three brief 
seizures in an hour, or the baby had a single seizure lasting more  
than 3 minutes. (11, 12) Current clinical practice is to treat clinical and  
prolonged, rather than electrical seizures. (8, 11) This practice is  
controversial because there is evidence that electroencephalographic 
seizures detrimentally affect the immature brain. The special 
problems of electroclinical dissociation and the short duration of 
neonatal seizures make it difficult to be sure when to start and stop 
anticonvulsant treatment.(8) The are good theoretical reasons for 
suppressing seizures activity but no clinical evidence that the general 
poor outcome can be improved with anticonvulsant treatment. 
Certainly, in a newborn who suffers from repeated seizures, there is  
a serious brain injury that includes disturbance in the cerebral blood 
flow, energy metabolism and homeostasis of excitotoxic amino 
acids.(8,49)  
1.10.1- Seizure control: 
    Prolonged or poorly controlled neonatal seizures have been 
associated with worse outcome than infrequent or readily controlled 
seizures, but the severity of the underlying disorder may account for 
both poor seizure control and adverse outcome. (12) There are no 
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clinical data which show that anticonvulsant treatment alters 
neurodevelopment outcome when controlled for the underlying 
neurological disorder.(8,12) Many of the commonly used 
anticonvulsants regiments are ineffective in controlling all seizures,  
clinically or electrically. Abnormal EEG activity still persists in  
a significant proportion of neonates who are clinical 
responders.(12,50,51)  
1.10.2- Anticonvulsants:   
   Many drugs have been used in the management of neonatal 
seizures.  Treatment is best started intravenously as absorption is 
erratic from intramuscular or enteral administration, and the neonate 
has little muscle mass. Facilities to site and maintain intravenous 
lines and to institute artificial ventilation are necessary before treating 
seizures, as most of the available drugs depress respiration and 
ventilation can become inadequate owing to frequent convulsions. 
The high total body water of the neonate means there is a large 
volume of distribution, hence the relatively large loading doses 
suggested. Many of the drugs are protein bound and can   
interact with other drugs and bilirubin.  (11) 
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Suggested approach to anticonvulsant treatment: (12)  
Loading  Maintenance 
 
1- Phenobarbitone 20 mg/kg (I V) 
 
2- Repeat Pbenobarbitone  10mg/kg dose, up  
 
to a further 20 mg/kg IV  
  
3- Colnazepam 100-200µg/kg(Iv over 30s 
 
4- Colonazepam IV. Infusion 10-30µg/kg/h 
 
5- Phenytoin 20mg/kg(IV rate <1 mg/kg/m 
 
  Paraldehyde 200-400mg/kg(per rectum or IV) 
 
    Sodium valporate 20mg/kg(oral) 
 
    Pyridoxine 100mg IV with EEG monitor  
 
 
6 mg/kg/d 
 
6mg/kg/d 
 
 
 
Once control 
achieved convert to 
daily dose 
 
Not recommended 
 
15-150mg/kg/h 
IV(5% solution in 
5%dextrose 
10 mg/kg 12 hourly 
 
 
   Phenobarbitone:  
   Is the most popular first line anticonvulsant. An initial intravenous 
loading dose of 20 mg/kg, further 10 mg/kg doses are administered to 
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a final loading dose of 40 mg/kg (approximate serum concentration 
180 mmol/l). The maintenance dose is 6 mg/kg/day, given 12 hourly 
in divided doses (therapeutic range 90-180 mmol/l). (11, 12) The half life  
(3-8 days) is prolonged in hepatic impairment. As well as its 
anticonvulsant activity, phenobarbitone decreases CNS metabolic 
rate at high dose, reduces calcium entry after ischaemia, and is a free 
radical scavenger. There have been concerns about toxic effects on 
the developing brain. (11, 12)  
The second Line Drugs: 
   Clonazepam may be used with a loading dose of 100-200 µ g /kg, 
followed by infusion at 10-30 µ g /kg/hour  if seizures continue. Other 
benzodiazepines are also popular. (12) 
   Lorazepam has been used successfully,(12, 52) although it may  
induce myoclonus in low birth weight infants.(12, 53)  Diazepam has an  
extremely short duration of action with a risk of sudden respiratory  
depression and its use should be avoided.  
   Phenytoin can be a useful addition to achieve seizure control. A 
loading dose of 20 mg/kg but do not continue further treatment 
because of its depressive effect on the neonatal myocardium and its 
unpredictable metabolism. (11, 12)  
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    Lignocaine; a class Ia anti-arrhythmic agent, which is thought to 
suppress seizures through inhibition of sodium entry. A loading dose 
of 2 mg/kg, followed by infusion of 6 mg/kg/hour, was effective in 
treating neonatal seizures refractory to phenobarbitone.(12) Prolonged 
infusion may result in accumulation of metabolites and may be 
responsible for cases of repeated seizures on withdrawal. (12, 54) 
Clearance is reduced in preterm infants and monitoring of plasma 
concentrations may be advisable (therapeutic range 3-6 mg/l).(12) 
Lignocaine should not be used together with phenytoin as serious  
cardiac arrhythmias can develop. 
   Paraldehyde can be a useful adjunct. (12) It has a relatively short half 
life (12 - 24 hours); elimination is by hepatic metabolism and 
pulmonary transport and is unaffected by altered renal function. 
Reported side effects include hepatic necrosis and pulmonary 
oedema. (11) A loading dose of 200-400 mg/kg can be given rectally or 
intravenously, followed by an infusion of 15-150 mg/kg/hour to 
achieve seizure control (0.3-3 ml/kg/hour of a 5% solution, made up in 
5% dextrose). Plastic syringes need to be changed every 12 hours  
and the solution should be protected from light.  
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   Sodium valproate has been used to treat intractable seizures, using 
an oral loading dose of 20 mg/kg, followed by 10 mg/kg 12 hourly.(12) 
There is a wide variation in plasma clearance, necessitating 
monitoring of drug concentrations (therapeutic range 185-425  
mmol/l). There are concerns about hepatotoxic effects. In the series 
reported hyperammonaemia was observed in all cases; half resolved 
spontaneously and half resolved after withdrawal of the drug.(11, 12)  
  An infusion of chlormethiazole has occasionally been used to control  
intractable seizures,(12) although there is little published evidence to 
support its use. In individual clinical cases each additional 
anticonvulsant used should prompt a critical reappraisal of the need 
for further treatment, as side effects may be potentiated by multiple 
anticonvulsants. Anticonvulsant treatment is advised to be withdrawn 
once seizures were controlled and the neurological examination is 
normal. Subsequent EEGs did not show recurrent seizures or 
multiform epileptiform activity.(12, 55)In most cases, this can be 
achieved prior to discharge from the neonatal unit. (11, 12)        
   Concern about the effect of anticonvulsant treatment on the 
developing brain, means that many neonatologists would only 
discharge a baby on maintenance phenobarbitone if neurological 
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examination was abnormal, discontinuing treatment before discharge 
in those who were neurologically normal. For infants who are 
discharged on anticonvulsants consider discontinuation of treatment if 
the baby is seizure free at 9 months. (11) In older children, treatment 
duration generally is one to two years after seizure control is 
achieved. It is important to differentiate neonatal seizures from 
neonatal-onset epilepsy, (56) because there are major implications for 
continuing maintenance antiepileptic drugs (AED) therapy.  These 
may occur even in the intrauterine period. (57, 58) Neonatal onset-
epilepsies include benign neonatal convulsions, benign neonatal 
familial convulsions, neonatal myoclonic epilepsy, and early infantile 
epileptic encephalopathy (known as Ohtahara syndrome). The first 
two have a benign prognosis, with resolution of seizures in most 
cases; the others have seizure recurrence and require AED 
treatment.  
 
   A specific cause requiring specific treatment should be excluded, if 
possible, such as basic metabolic disorders, the inborn errors of 
metabolism (IEM), (59) and certain dependency and deficiency states. 
The oral daily maintenance dose of pyridoxine was 200 mg/day. (41) 
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1.11- Prognosis: 
   Clinical semiology is predictive of outcome in neonatal seizures and  
suggests the presence of unique pathophysiologic processes for 
different seizure types. But it is important to remember that the 
aetiology of seizures may be the most important factor in determining 
outcome. (6, 7, 8, 12) Poor prognosis has been noted in patients with 
CNS malformation and hypoxic-ischaemic insults, while primary 
subarachnoid haemorrhage and isolated hypocalcaemia are 
associated with a favorable outcome. (6, 7, 8) Early hypoglycaemia, 
CNS infections, and hypoxia-ischaemia have an intermediate 
prognosis (30-50% normal). The prognosis following isolated  
hypocalcaemia or benign familial neonatal seizures is excellent. 
Seizure characteristics associated with adverse outcome are 
generalized myoclonic or tonic seizures, intractable seizures, and 
burst suppression or persistent low voltage EEG states. (12) A normal 
interictal EEG is associated with a good outcome. Other clinical 
factors associated with poor outcome are persisting neurological 
abnormalities on clinical examination and very low birth weight. Only 
25% of infants less than 31 weeks of gestation had a normal outcome 
after EEG confirmed seizures, compared with 60% of term infants. (12) 
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The prognosis in infants respond to first line anticonvulsant is better 
than in those who require second line treatment. (12, 60) In the last  
years, some important studies (61, 62) have reported significant 
improvement of degree of seizures control in neonates, using new 
anticonvulsant drugs (second line anticonvulsants ). More recently, it 
seems that lignocaine has a narrow therapeutic range and it can 
induce seizures in high doses. The drug can accumulate and so 
cannot be infused over very prolonged periods. Although there are 
some encouraging results with lignocaine, midazolam and 
clonazepam in particular in neonates with status epilepticus, the long  
term outcome of these children is not significantly improved. (8) 
Children with neonatal seizures but who subsequently were 
considered to have a normal outcome were followed up in their late 
teenage years and found to have difficulties with spelling, arithmetic 
and memory, despite having normal overall intelligence. (8, 12, 63, 64) 
This suggests that the underlying CNS vulnerability which contributes 
to neonatal seizures is associated with longer term clinical 
importance. (8, 12)              
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1.12- Justifications 
1- Seizures are predictive of serious illnesses and 
indicator of morbidity and mortality in neonate. 
2- No similar study done in Sudan. 
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1.13- Objective 
1- To study clinical pattern of neonatal seizures. 
2- To study the possible underlying causes and 
co-related factors of neonatal seizures. 
3- To detect short term outcome in the neonatal period. 
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2- Patients and method 
2.1- Study design: 
Prospective, cross sectional, hospital based study. 
2.2- Study area: 
The study was conducted in five hospitals: 
1- Omdurman Maternity Hospital (OMH). 
2- Soba University Hospital (SUH). 
3- Khartoum Children Emergency Hospital (KCEH). 
4- Omdurman Children Emergency Hospital (OCEH). 
5- Ahmed Gasim Hospital (AGH). 
2.3- Study period: 
        The study was conducted during August 2004 to February 2005. 
2.4- Study population: 
        The study included 75 neonates with seizures admitted 
into study area hospitals during study period. 
2.5- Inclusion criteria: 
        Neonates with seizures during study period in the study area. 
2.6- Exclusion criteria: 
         Refusal of the parents or the care givers. 
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2.7- Sample size: 
     The number of patients was 73 neonates according to equation:(65) 
N = Z2 pq /d2 
N = sample size 
Z = statistical certainty (1.96) 
P = prevalence = 0.05 (6) 
Q = probability of failure 1- P = 1-0.05= 0.05 
D = desired margin of error = 0.05 
2.8-Study technique: 
2.8.1- Consent: 
        Verbal consent was obtained from the parents or care givers 
before filling the questionnaire. Informed consent was obtained from 
the hospital director and treating doctor. 
2.8.2- Research team: 
       Researcher and pediatric registrars in charge filled the 
questionnaire and conducted physical examination. 
      One statistician who entered the data and did the interpretation 
with the help of the author. 
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2.8.3- Research tools and methods: 
2.8.3.1- Questionnaire: 
       A through and comprehensive history was obtained about 
personal data, mother, prenatal, natal history, pattern of seizures and 
correlated factors. The findings of the clinical examination, 
investigations done, treatment given and the outcome. The data was 
entered in designed questionnaire.  Appendix(1).   
Patients were taken as they were diagnosed by their treating 
doctors. They were followed up in the acute phase of illness till 
discharge, then in the referral clinics or contacted by phoning till the 
end of the neonatal period assessing the neonatal period outcome. 
2.9- Statistical analysis: 
     The data was analyzed by the computer using the statistical 
package for social sciences system (SPSS). Chi- square test is used 
to compare the data. P. value of less than 0.05 was regarded as 
significant. Sensitivity and specificity tests were used for some 
variables. 
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3. RESULTS 
 
A total of 75 newborns with different types of seizures were 
studied. There were 30, 21, 11, 8, 5 cases from Maternity hospital, 
Khartoum Children Emergency Hospital, Omdurman Children 
Emergency Hospital, Ahmed Gasim Hospital and Suba University 
Hospital respectively. 
3.1- Sex distribution of study cases: 
     There were 44 (59%) males and 31 (41%) females.(Figure 1). 
3.2- Parity of mothers of the study cases: 
    Twenty six (34.7%) mothers were primiparae, 25 (33.3%) were 
multiparae and 24 (32%) were grand multiparae.(Figure 2). 
3.3- Ante-natal care of mothers of the study cases: 
  The mothers of study cases 61 (81.3%) had a regular ANC, six (8%) 
had irregular ANC and eight (10.7%) had no ANC.(Figure 3). 
3.4- Place of delivery of study cases: 
Most of the newborns 51 (68%) were delivered at hospitals and 
only 24 (32%) were delivered at home.(Figure 4). 
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3.5- Mode of delivery of study group:  
Forty eight (64%), five (6.7%), eight (10.7%), seven (9.3%) and 
seven (9.3%) of study cases were delivered by NVD, Accelerated VD, 
Assisted VD, Em C/S and El C/S respectively.(Figure 5). 
3.6- Delivery attendant of study cases:  
 The delivery in 51 (68%) cases was attended by trained midwives, 
21 (28%) by doctor, two (2.7%) untrained midwife and one (1.3%) 
was delivered alone. (Figure 6) 
3.7- Mode of presentation at delivery of study cases: 
As shown in (Figure 7), 74 (98.7%) of cases presented 
cephalically and only one was breech presentation at time of delivery. 
3.8- Gestational age of study cases:  
Seventy (93.3%) of cases were delivered at term, three (4%) 
were preterm and two (2.7 %) were post term. (Figure 8) 
3.9- Weight distribution of study cases:  
Seventy two (96%) were between 3rd and 97 percentile, two (2.7) 
were at > 97th and only one was at < 3rd percentile. (Figure 9) 
3.10- Breast feeding initiation in study cases:  
         Thirty six (48%) were breast fed within the first two hours, 28 
(37.7 %) after more than two hours and 11 (14.7%) were not breast  
fed ( on formula milk). (Figure 10)    
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3.11- Seizure types and risk factors: 
  As (Table 1) shows, ten mothers developed abnormal vaginal 
discharge, nine of their newborns had multifocal seizures while only 
one had developed focal seizures. Six mothers with irregular ANC, 
four of their newborns had multifocal seizures, one had focal seizures 
and one with tonic seizures. Eight mothers with no ANC, six of their 
newborns had multifocal seizures, one had focal seizures and one 
with tonic seizures. Maternal DM was found in three mothers, two of 
their newborn had focal seizures and one had subtle seizures. 
Maternal hypertension was found in four mothers, three of their 
newborns had multifocal seizures and one had focal seizures. 
Prolonged rupture of membrane and UTI were found in four mothers, 
three of their newborn developed multifocal seizures and one 
developed tonic seizures.    
3.12- Age at the time of the first attack of seizures: 
Twenty two (29.3%), 24 (32%),13 (17.3%) and 16 (21.3%) of cases 
developed seizures within one, ( > 1- 3), (> 3-7) and > 7 days of  life 
respectively.(Table 2). 
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3.13- Clinical pattern of seizures in the study cases: 
The majority 55 (73.3%) of seizures were multifocal, 10(13.3%) 
were focal, seven (9.3%) were tonic, two (2.7%) were subtle seizures 
while only one was myoclonic type.(Table 3). 
3.14- Presenting symptoms of the study cases: 
Presenting symptoms in the study cases were refusal of 
feeding, fever, disturbance of consciousness, umbilical discharge, 
umbilical stump bleeding and vomiting in 42(56%), 36(48%), 17 
(22.7%), 9 (12%), 4 (5.3%) and 3 (4%) respectively.(Table 4). 
3.15- Presenting signs in the study cases: 
Presenting signs in the study cases were pallor, jaundice, 
cyanosis, fever, hypothermia, tachypnea, apnea, tachycardia, 
umbilical discharge, hepatomegally, abscent or diminished primitive 
reflexes, hpotonia, hypertonia and skin pustules.(Table 5). 
3.16- Investigations done for the study cases: 
The investigations were done selectively for cases to determine 
the aetiology. These were RBS, serum Ca+2, serum PO3, serum Na+, 
serum Mg+2, serum bilirubin, lumber puncture, cranial US and brain 
CT scan.(Table 6). 
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3.17-  A etiological diagnosis of the study cases: 
Neonatal sepsis was the aetiology of seizures in 40(53.3%), 
birth asphyxia in 19 (25.3%), intra-cranial hemorrhage in three (4%), 
meningitis in two (2.7%), encephalitis in one (1.3%), infected 
meningomylocel in one (1.3%) and metabolic disturbances in 
7(9.3%). (Table 7). 
3.18- Medication taken by study cases: 
       Medications received by the study cases according to the 
aetiological causes of seizures were dextrose, calcium gluconate, 
magnesium, diazepam, phenobarbitone, phenytoin, pyridoxine, 
antibiotic, oxygen, chloroquine, blood, phototherapy, pretonial 
dialysis, Acyclovir, aminophylline, vit.K and chlorpromazine.(Table 8). 
3.19- Seizure type and gender: 
      There were thirty one male developed multifocal seizures, seven 
focal and six tonic seizures. While 24 females shown multifocal, two  
subtle, one tonic and one myoclonic seizures.(Table 9). 
3.20- Presenting symptoms and type of seizures: 
Refusal of feeding was the symptom in 33 cases with multifocal 
seizure, five with focal, three with tonic and one with subtle seizures. 
Fever in 27 with multifocal, five with tonic and four with focal seizures. 
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Disturbence of conciousness in 14 with multifocal and one in focal, 
subtle and myoclonic seizures. Umbilical discharge in seven with 
multifocal and two with tonic seizures. Umbilical stump bleeding was 
found to be the presenting symptom in four cases with multifocal 
seizures.(Table 10). 
3.21- Presenting signs and seizure types: 
(Table 11) shows the relation between the presenting signs and 
type of seizures in the study cases. 
3.22- Seizure types and aetiological diagnosis:  
Neonatal sepsis was the cause in 40 (53.3%) of which 
29(72.5%) had multifocal seizures, six (15%) had focal, five (12.5%) 
had tonic seizures. Birth asphyxia was found in 19(25.3%) of which 
13 (68.4%) had multifocal, three (15.8%) had focal, two (10.5%) had 
subtle and one (5.3%) had tonic seizures. Intracrainial haemorrhage 
was fond in three cases two of them had multifocal and one with focal 
seizures. Metabolic disturbeces was fond in seven (9.3%) four of 
which had multifocal, two had focal and one with myoclonic 
seizures.(Table12). 
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3.23- Aetiological diagnosis and age at first attack 
of seizures: 
As Table13 shows, seizures occur in the first 24 hours mainly in 
cases with birth asphyxia, metabolic disturbances and some cases of 
neonatal sepsis. Seizures developed within deferent age groups   in 
the other aetiological factors. 
3.24- Seizure types and outcome during acute illness: 
   Eleven out of 55 cases with multifocal seizures died and three 
out of ten with focal seizures died, one of the two cases with subtle 
seizures died, two out of seven cases with tonic seizures died.     
(Table14). 
3.25- Seizure types and out come in the neonatal period: 
Thirty six out of 44 cases with multifocal seizures return to 
normal, two had some improvement, five had residual neurological 
signs and one died. All cases with focal, tonic and subtle seizures 
returned to normal in late neonatal period, while only one of the four 
cases with myoclonic seizures returned to normal and the three show 
residual neurological signs.(Table15). 
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Table 1 Seizure types and risk factors 
Type of seizure  
Risk factor multifocal focal 
 
subtle 
 
tonic 
 
myocolonic 
 
total 
Good ANC. 45 8 2 5 1 61 
Irregular ANC. 4 1 0 1 0 6 
No ANC. 6 1 0 1 0 8 
PIH. 2 1 0 0 0 3 
Maternal  DM. 0 2 1 0 0 3 
Polyhydramnious 1 0 0 0 0 1 
Maternal hypertention 1 0 0 0 0 1 
Abnormal vaginal discharge 9 1 0 0 0 10 
Maternal UTI 1 0 0 0 0 1 
PRM 2 0 0 1 0 3 
 
             P = 0.221
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Table 2 Age at the time of first attack of seizures 
Age frequency % 
24 hr 22 29.3 
› 24-72 hr 24 32 
› 72 hr- 1 week 13 17.3 
›1 week- 4 weeks 16 21.3 
Total 75 100 
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Table 3 Clinical pattern of seizures  
 
Pattern frequency % 
Multifocal 55 73.3 
Focal 10 13.3 
Tonic 7 9.3 
Subtle 2 2.7 
Myocolonic 1 1.3 
Total 75 100 
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Table 4 Presenting symptoms among the cases  
 
symptom frequency % 
Fever 36 48 
Refusal of feeding 42 56 
Vomiting 3 4 
Disturbance of 
consciousness  
17 22.7 
Bleeding 4 5.3 
Umbilical discharge 9 12 
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Table 5 Presenting signs in study cases  
Sign Frequency % 
Pallor 9 12 
Jaundice  17 22.7 
Cyanosis 6 8.6 
Fever 26 34.7 
Hypothermia 4 5.3 
Tachapnoea 21 28 
A pnoea 5 6.7 
Tachycardia 1 1.3 
Bradycardia 3 4 
Crackles 14 18.7 
Abdominal distention 2 2.7 
Umbilical infection 13 17.3 
Hepatomegally 8 10.7 
Absent primitive reflexes 8 10.7 
Diminished primitive reflexes  18 24 
Hypertonia 8 10.7 
Hypotonia 16 21.3 
Skin pustules 4 5.3 
 
 
 
 
 
 58 
Table 6 Investigations done for study group 
 
Done Normal Abnormal 
 
Investigation 
(N)          % (N)        %     (N)        % 
RBS 53 70.7 45 60 8 10.7 
S. Ca+2 41 54.7 27 36 14 18.7 
S. PO3 2 2.7 2 2.7 0.0 0.0 
S. Na+ 16 21.3 2 2.7 14 18.7 
S. Mg+2 5 6.7 3.0 4.0 2 2.7 
S. bilrubin 26 34.7 3.0 4.0 23 30.7 
L.P. 2 2.7 0.0 0.0 2 2.7 
Cranial U/S 7 9.3 3.0 4.0 4 5.3 
Brain CT 1 1.3 0.0 0.0 1 1.3 
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Table 7 Aetiological diagnosis of the cases 
DIAGNOSIS No % 
Neonatal sepsis 21 28 
N. sepsis + jaundice 7 9.33 
N. sepsis + ARF 3 4 
N. sepsis + hypoglycaemia 4 5.33 
N. sepsis + hypocalcaemia 3 4 
N. sepsis + kernicterus 1 1.33 
N. sepsis + malaria 1 1.33 
Birth asphexia 15 20 
Birth asphexia hypocalcaemia 2 2.66 
Birth asphexia + hypoglycaemia 1 1.33 
Birth asphexia + jaundice 1 1.33 
Intera ceanial haemorrhage 3 4 
Hypocalcaemia 3 4 
Hypoglycaemia 3 4 
N. tetanus + hypocalcaemia 2 2.66 
Meningitis 2 2.66 
Encephalitis 1 1.33 
Infected meningomylocel + hypocalcaemia 1 1.33 
Hypocalcaemia + hypomagnesaemia 1 1.33 
TOTAL 75 100 
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Table 8 Medications taken by study group 
 
Medication No % 
Dextrose 73 97.3 
Ca+2 gluconate 37 49.3 
Mg+2  3 4.0 
Diazepam 37 62.7 
Phenobarbitone 52 69.3 
Phenytoin 21 28 
Pyridoxine 4 5.3 
Antibiotics 70 93.3 
Blood transfusion 3 4 
Exchange transfusion 3 4 
Phototherapy 12 16 
Incubation  2 2.7 
Oxygen  23 30.66 
Chloroquine 1 1.33 
Peritoneal dialysis 1 1.33 
Vit. K 7 9.33 
Acyclovir 1 1.33 
Aminophylline 5 6.66 
Chlorpromazine 1 1.33 
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Table 9 Seizure types and gender of the cases 
 
 
Seizure type Gender 
Focal Multifocal Tonic myoclonic Subtle TOTAL 
Male 7 31 6 0 0 44 
Female 3 24 1 1 2 31 
TOTAL 10 55 7 1 2 75 
 
 
            P = 0.135 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 62 
 
Table 10 Presenting symptoms and seizure types 
 
Type of seizures symptom 
multifocal focal subtle tonic Myoclonic P 
Fever 27 4 0 5 0 0.332 
Refusal of feeding 33 5 1 3 0 0.682 
Umbilical discharge 7 0 0 2 0 0.460 
Vomiting 2 1 0 0 0 0.849 
Disturbance of 
consciousness 
14 1 1 0 1 0.113 
Bleeding tendancy 4 0 0 0 0 0.820 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
           
 
 63 
Table 11 Presenting signs and seizure types  
Type of seizures  Sign 
multifocal focal subtle tonic Myoclonic  
Pallor 7 0 1 1 0  
 Jundice 11 2 1 2 1  
Cyanosis 4 1 0 0 1  
Febrile 3 1 0 0 0  
Hypothermia 18 3 0 5 0  
Apnoea 4 1 0 0 0  
Tachpnoea 15 3 1 1 1  
Tachcardya 1 0 0 0 0  
Bradycardya 2 0 1 0 0  
Crackle 10 2 0 2 0  
Abdominal 
distention 
2 0 0 0 0  
Umblical infection 8 2 0 3 0  
Hepatomegaly 4 1 0 2 1  
Abcent primitive 
reflexes 
37 7 1 4 0  
Diminished primitive 
reflexes 
14 2 0 2 0  
Hypotonia 10 3 1 1 1  
Hypertonia 4 1 0 3 0  
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Table 12 Seizure types and aetiological diagnosis 
Type of seizures Aetiological diagnosis 
multifocal focal subtle tonic Myoclonic 
Neonatal sepsis 15 4 0 2 0 
N.S.+ Jaundice 5 0 0 0 0 
N.S. +  ARF 4 1 0 1 0 
N.S.+ hypoglycaemia 4 0 0 0 0 
N.S. + hypocalaemia 3 0 0 1 0 
N.S. +  kernicterus 0 1 0 0 0 
N.S.+ malaria 0 0 0 1 0 
Birth asphexia 11 2 2 0 0 
B. asphexia+hypocalaemia 2 0 0 0 0 
B.asphexia+hypoglycaemia 0 1 0 0 0 
B. asphexia +jaundice 0 0 0 1 0 
Intra cranial haemorrhage 2 1 0 0 0 
Hypoglycaemia 2 0 0 0 1 
Neonatal tetanus 
+hypocalaemia 
1 0 0 1 0 
Meningitis 2 0 0 0 0 
Encephalitis 1 0 0 0 0 
Infected meningomylocele   
+ hypocalaemia 
1 0 0 0 0 
Hypocalaemia + 
hypomagnesaemia 
1 0 0 0 0 
Total  55 10 2 7 1 
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Table 13 Aetiological diagnosis and age at first attack of 
seizures 
Age at first attack of seizures Aetiological diagnosis 
24hr >24-72hr >72hr-1wk 1-4wks 
Neonatal sepsis 6 9 2 4 
N.S.+ Jaundice 0 3 2 2 
N.S. +  ARF 0 0 0 4 
N.S.+ hypoglycaemia 1 1 2 0 
N.S. + hypocalaemia 1 1 2 0 
N.S. +  kernicterus 0 0 0 1 
N.S.+ malaria 0 0 1 0 
Birth asphexia 10 4 0 1 
B. asphexia+hypocalaemia 2 0 0 0 
B.asphexia+hypoglycaemia 0 1 0 0 
B. asphexia +jaundice 1 0 0 0 
Intra cranial haemorrhage 0 2 1 0 
Hypocalaemia 1 0 0 2 
Hypoglycaemia 0 1 1 0 
Neonatal tetanus 
+hypocalaemia 
0 0 1 1 
Meningitis 0 1 1 0 
Encephalitis 0 0 0 1 
Infected meningomylocele   + 
hypocalaemia 
0 1 0 0 
Hypocalaemia + 
hypomagnesaemia 
1 0 0 0 
Total  22 24 13 16 
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Table 14 Seizure types and outcome during acute illness 
 
 
Outcome during acute illness Seizure type 
Improved Died total 
Multifocal 44 11 55 
Focal 7 3 10 
Subtle 1 1 2 
Tonic 5 2 7 
Myoclonic 1 0 1 
TOTAL 58 17 75 
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Table 3.15 Seizures types and outcome during neonatal period N=58 
 
 
Outcome in the neonatal period  Seizure type 
Retain to normal Some improvement Residual neurological sign Died total 
Multifocal 36 2 5 1 41 
Focal 7 0 0  7.0 
Subtle 1 0 0  1.0 
Tonic 5 0 0  5.0 
Myoclonic 1 0 3  4.0 
Total 47 2 8 1 58 
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Figure 1 Sex distribution of study cases 
 
 
 
31
41%
44
 59%
Males Females
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 69 
Figure 2 Parity of mothers of study cases  
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Figure 3 Ante-natal care of mothers of study cases 
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Figure 4 Place of delivery of study cases 
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Figure 5 Mode of delivery of study cases 
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Figure 6 Delivery attendant of study cases 
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Figure 7 Mode of presentation at delivery of study cases 
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Figure 8 Gestational age of study cases 
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Figure 9 Weight distribution of the study cases 
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Figure 10 Breast feeding in the study cases 
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4- Discussion 
In a seven months study 75 newborn with seizures were 
studied, since they developed first attack of seizure till they were 
discharged from hospitals and then they were followed up to the end 
of the neonatal period.  
The total number of cases is more than cases studied in Nigeria 
by Asindi et al,(16)  Ariede et al (15) and Omene et al.(14) There were 30, 
5, 21, 11 and 8 cases from OMH, SUH, KCEH, OCEH and AGH 
respectively. Representing frequency of 2.3%, 1.5% of INCU in OMH 
and SUH respectively. The cases represent 0.21%, 0.23% and 0.07% 
of general pediatric cases admitted in KCEH, AGH and OCEH 
respectively. While over all frequency of neonatal seizures was 4% in 
Omene et al (14). Incidence of 0.75% per live births was reported by 
Ariede et al(15) and of 0.35% per live births by Asindi et al.(16) 
There was male preponderance to seizures than female as 
found in studies done in Nigeria (14,15,16) 
The study cases were born at term with exception of three 
preterm and two post term deliveries while more preterm neonates 
were reported in literature. (14,15.16)     
 79 
 The first attack of seizures was developed at the following age 
groups, 29.3% of cases in < 1 day of age, 32% in 1-3 days, 17.3% in 
> 3-7 days and 21.3% in > 7 days of age (Table 2). This is not similar 
to 50% 1n < 1 day as reported by Asindi et al.(16)    
          It is postulated that the early (within 48 hours) rate of seizures 
in newborns would provide a sensitive indicator of quality of obstetric 
care. (15) With 61.33% of seizures in this study occurring within first  
48 hours, much still needs to be done to improve perinatal care in our 
country. 
The clinical pattern of seizures in this study there were 73.33%  
multifocal, 13.33% focal,  9.33% tonic, 2.7% subtle and  1.3% 
myoclonic seizures (Table 3), while  Asindi et al(16)  observed to be 
mixed (focal and generalized) in 63.3%, constantly focal 33.7% and 
unclassified in three newoborns. The high prevalence of multifocal 
seizures 73.33 % encountered in this study may be related to the 
mixed aetiology involving a comparatively large number 36 % of 
cases. These adverse factors acting simultaneously could probably 
excite the brain more extensively, thus producing a rather aggressive 
electrical discharge to manifest generalized (multi) instead of a 
constantly focal pattern. 
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The study showed the significant role of neonatal sepsis (53%) 
and birth asphyxia (25%) as aetiologic factors of neonatal seizures. In     
to studies conducted in Nigeria; Asindi et al (16)  reported birth 
asphyxia, infections and hypoglycaemia in order of decreasing 
frequency, while Omene et al(14) reported birth asphyxia and 
hypoglycaemia as the main aetiological factors and Ariede et al (15) 
reported  birth asphyxia as single most common case of neonatal 
seizures.   
 The over all mortality was 18 (24%) of cases mainly in the 
acute illness and one in neonatal period. Seizure type encountered in 
died cases were 11 multifocal, three focal, two tonic and one subtle in 
the acute illness, the one who died during neonatal period showed 
myoclonic seizures.  
The study shows that the outcome is related to multiple factors; 
the eighteen neonate who died, 11 (61.11%) of them had multifocal 
seizures. Neonatal sepsis was the aetiology in 12 (66.66%) and birth 
asphyxia in four (22.22%). Nine of them developed seizure in the first 
48 hours of life. 
Prognosis for neonates is steadily improving in tune with better 
obstetrical management and intensive neonatal care in well equipped 
centers. (16,66) The lack   of   essential  facilities  for  managing both 
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term and preterm infants in our care made it difficult to improve the 
chances of the potentially salvageable neonates. 
It is likely that more revelations could have been made if all the 
infants were subjected to full investigation. Without facilities for 
extensive biochemical screening, imaging techniques and viral 
studies, it has been impossible to determine the role of some disease 
conditions which have not featured in this study. For  example in-born 
errors of metabolism, TORCH infections, cerebral dysgenesis and 
periventricular or intraventricular haemorrhages amongst other 
factors. 
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Conclusion 
• Neonatal seizure is still a problem that needs a lot of effort to be 
done. 
•  Multifocal seizures were the most common pattern in the study. 
• Most of newborn developed seizures in first 48 hours of life.  
• Neonatal sepsis and birth asphyxia were the main aetiological 
factors followed by metabolic causes. 
• Poor prognosis was associated with multifocal seizures, sepsis, 
birth asphyxia and the development of seizures in the first 48 
hours of life. Besides increasing mortality and morbidity among 
the neonates.     
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Recommendations 
• More diagnostic and therapeutic facilities craved be provided to 
enhance accurate identification and possible treatment of the 
causative factors.  
• More health educational efforts need to be directed at expectant 
mothers who should be encouraged to use the available health 
establishments for antenatal care and safe delivery.  
• Early notification and presentation of neonates who develop 
seizures by their mothers or care givers, is mandatory if 
morbidity and mortality are to be minimized. 
• High risk pregnancies should be monitored at tertiary level of 
care with well equipped centers and well integrated work 
between obstetric and neonatology services to reduce birth 
asphyxia, prematurity and infection.        
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University of Khartoum 
The Graduate College 
Medical & Health Studies Board 
Questionnaire 
Clinical Pattern of Neonatal Seizures in Khartoum State 
 
Date: ………………… 
Serial No. 
Hospital: 
1) Maternity         2) Soba       3) Khartoum C.E.H      
4) Omdurman C.E.H            5) Ahmed Gasim H. 
1) Personal data: 
1.1. Name ………………………………………………. 
1.2. Birth date  
1.3. Sex:    1) Male        2) Female  
1.4. Residence: …………………………… Tel. No. …………… 
1.5. Tribe ………………………………….. 
2) Mother and prenatal: 
2.1. Mothers name ………………… 
2.2. Mothers age ……………………. 
2.3. Occupation……………………… 
2.4. Pregnancy   1) Normal   2) Invetrofertalization  
2.5.  Parity: 
 1) PG              2) < P5               3) ≥ P5 
2.6. Known maternal disease: 
 1) DM             2) Hypertension   3) Other specify  
……………………………………………………………………… 
 
  2 
2.7. Antenatal care a tendency: 
 1) Yes             2) No              3) Irregular 
2.8. History of illness during pregnancy:   1) yes     2) No 
      If yes specify        1.  yes     2. no        
1) Pregnancy induced  hypertension                       
2) Polyhydraminous. 
3) Multiple pregnancy.                                                     
4) Systemic infection. 
5) Abnormal vaginal discharge. 
6) U.T.I or   Pyelonephritis. 
7) Prolong rupture of membrane ( > 12 hrs). 
2.9. Drugs received during pregnancy:  1) Yes           2) No    
           If yes specify ……………………………………….. 
3) Natal history: 
3.1. Place of delivery: 1) Home           2) Hospital 
3.2. Home delivery by: 
1) Trained midwife. 
2) Untrained midwife. 
3) Alone. 
4) Doctor 
3.3. Presentation:  1) Cephalic             2) Breech     
                             3) Other malpresentation……………………………….  
3.4. Mode of delivery: 
1) N.V.D            2) Accelerated V.D.       3) Indused V.D.  
 4) Assisted V.D   5) EL C/S       6) Em C/S 
3.5. Gestational age: 
 1) < 37 wks        2) 37 – < 42 wks        3) ≥ 42 wks  
3.6. If multiple pregnancy  1) First T.  2) 2nd T.  3) 3rd T. 
3.7. Cry after delivery:  1) Immediately        2) Not immediately  
3.8. Colour:                     1) Pink       2) Pale       3) Blue 
  3 
3.9. Breast feeding: 1) Immediately < 2hr. 2) Not Immediately 3) Not BF  
3.10. Resuscitation:  1) Yes        2) No 
If yes treatment receives. 
1) Oxygen       2) Suction         3) Stimulation and warning 
4) Bag and mask                       5) Chest compression      
6) Endotracheal intubation       7) 1 & 2      
8) 1, 2 & 3        9) 1,2,3,&4     10)All of the above 
3.10. Apgar score at 5 minute: 
 1) < 3       2) > 3 
4) Seizures: 
4.1. Age at first attack of seizure.  1)  24 hr                      2) > 24 – 72 hr   
                                                        3) > 72 hr – 1 wk      4) > 1 – 4 wks 
4.2. Seizure type: 
1) Focal seizure.      2) Multi focal      3) Tonic 
     4) Myoclonic               5) Subtle seizure  
4.3. Number of attacks of seizures:  1) One      2) Two    3) >Two 
5) Other presenting complains: 
5.1. Fever:                         1) Yes        2) No 
5.2. Refusal of feeding:    1) Yes        2) No 
5.3. Umbilical discharge:  1) Yes        2) No 
5.4. Vomiting:                   1) Yes        2) No 
5.5. Abnormal sleep or disturbance of consciousness: 1) Yes      2) No 
5.6. Bleeding tendency:                                                 1) Yes      2) No 
6) Examination:  
- Anthropometric measurement:  1) < 3rd canticle   2) 3rd - 97th 3) > 97th    
6.1.  Wt (kg)……………… 
6.2. HC (cm) ……………... 
6.3. Length (cm)………….. 
 
  4 
6.4. Dysmorphic features:                1) Yes    2) No 
If yes specify:…………………………………………………………… 
…………………………………………………………………………… 
6.5. Pallor:        1) Yes    2) No 
6.6. Jaundice:    1) Yes    2) No 
6.7. Cyanosis:   1) Yes    2) No 
6.8. Temperature:     1) < 35.3°C    2) 35.3 – 37.3°C    3) > 37.3°C 
6.9. Respiratory rate/ minute:  1) ≥ 60      2) 30 – 59      3) <30 
6.10. Pulse rate/ minute:         1) > 220     2) 100 – 220   3) <100 
6.11. Breathing pattern:          1) Regular   2) A panic     3) Irregular  
6.12. Crackles:                        1) Yes         2) No 
6.13. Heart murmur:                1) Yes         2) No 
6.14. Abd. distention:              1) Yes         2) No 
6.15. Umbilical infection:        1) Infected  2) Not infected  
6.16. Organomegaly:       1) Liver      2) Spleen    3) Kidney  4) No 
6.17. Primitive reflexes: 1) Present    2) Diminished       3) Absent   
6.18. Tone:              1) Normal   2) Hypotonia   3) Hypertonia  
6.19. Skin:    1) Normal   2) Pustules    3) Purpura or petchii 
7) Investigations done: 1) Normal.    2) Low.   3) High. 
7.1. Random blood sugar.    ………………   
7.2. Serum Ca++.         ……………………………………. 
7.3. Serum PO3.    ………………………………………… 
7.4. Serum Na+.     ………………………………………….. 
7.5. Serum Mg++.    ………………………………………… 
7.6. S. bilurbin uncongugated.      …………………………… 
7.7. Sepsis work-up. 1) Blood culture. 2) Lumbar P. 3) Urine culture  
…………………………………………………………………………… 
7.6. Cranial U/S…………………………………………………….. 
7.7. Brain CT……………………………………………………… 
  5 
7.8. EEG…………………………………………………………… 
8) Diagnosis: …………………………………….………………… 
……………………………………………………….…………….…………… 
 
9) Treatment:                   1) Received       2) Not received. 
 9.1. Dextrose 10%. 
9.2. Ca++ gluconate. 
9.3. Mg++. 
9.4. Diazepam. 
9.5. Phenobarbeton. 
9.6. Phenytoin. 
9.7. Pyridoxin. 
9.8. Antibiotics. 
9.9.  Blood transfused.  
9.10. Exchange transfution. 
9.10. Incubater. 
9.11. Phototherapy. 
9.12. Oxygn. 
9.13. Others treatment specify 
……………………………………………………………………… 
 
10) Outcome during acute illness: 
 1) Improved      2) Deteriorated    3) Died  
11) Outcome during neonatal period: 
 1) Retain normal.      2) Some improvement     
3) Residual neurological sign.   4) Died  
